In the News: September 29-October 5, 2016

Sg2 is dedicated to helping our clients interpret the latest news and trends in health care. Below you’ll find our analysis of this week’s key industry headlines, along with links to related Sg2 resources.

CMS Expands Coverage for Hepatitis B Virus Screenings

On September 28, CMS released a Decision Memorandum for Screening for Hepatitis B Virus (HBV) Infection. This memorandum finalizes CMS’s decision to expand coverage of screening beyond pregnant women to asymptomatic nonpregnant adolescent and adult Medicare beneficiaries who are considered high risk for HBV infection, based on criteria described here.

CMS cited a 2014 Annals of Internal Medicine study, which stated that “approximately 700,000 to 2.2 million persons in the United States have chronic HBV infection.” On the journey to value-based care, developing and refining your chronic care strategy will become increasingly important. To learn more about innovative chronic disease management, watch this Sg2 webinar featuring Aurora Clinical Contact Center.

Beyond Sg2: Health Affairs Discusses “Why Great Ideas in Health Care Don’t Thrive Everywhere”

The authors of this recent Health Affairs blog post discuss the limitations in the propagation of promising forms of health care to dissimilar regions. From Kaiser Permanente to independent practice associations to provider-sponsored health insurance, the authors recap the regional variation in the adoption and penetration of health care organizations, which appear to thrive in certain areas, but utterly fail to gain traction in others.

At Sg2, we believe that health care is local and that the timing for executing your risk-based strategy is essential. Sg2 routinely assesses 4 leading indicators of risk readiness across hundreds of markets nationwide. To learn more, check out the resource kit featuring slides and recording from our Executive Summit, titled Timing Is Everything: Risk, Reward and the New Strategic Portfolio, and download our report, The Race to Risk—Tracking Markets’ Evolution Toward Value-Based Care.

“Investing Wisely in Health Care Capital”

An article published in JAMA last week implored health care leaders to invest wisely in health care capital, just as physicians and patients are encouraged to choose wisely in making clinical decisions. With rising stakes, capital expenditures continue to be an important driver of health care performance and should be evaluated carefully. The article describes how better tools and more sophisticated analysis need to be used to model future population health needs and determine key benchmarks for return on investment.

At Sg2, we provide analytics to guide health care leaders in making these key capital decisions. We appreciate the importance of understanding today’s and tomorrow’s population needs, and best deploying resources to position your organization to meet your community’s changing requirements. For details, see our report on developing a foundational framework in advanced analytics.

  • Share
  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube